Mineralys Therapeutics, Inc. (MLYS)
29.26
+0.23
(+0.79%)
USD |
NASDAQ |
Feb 27, 16:00
29.30
+0.04
(+0.14%)
After-Hours: 20:00
Mineralys Therapeutics Total Assets (Quarterly) : 599.95M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.265B |
| Nektar Therapeutics | 301.35M |
| Lyell Immunopharma, Inc. | 407.96M |
| Arrowhead Pharmaceuticals, Inc. | 1.604B |
| Celcuity, Inc. | 476.00M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.52M |
| Shareholders Equity (Quarterly) | 576.43M |
| Current Ratio | 25.50 |